According to a Food and Drug Administration advisory committee, over-the-counter cold and cough medicines don't work for young children. So what are parents supposed to do? MCR American Pharmaceuticals offers a solution.
Brooksville, Florida — September 3, 2012
For years, parents have relied on kids’ cold medicines and cough syrups to ease their children’s discomfort. However, the FDA and medical professionals now believe that over-the-counter cold and cough medicines should not be given to young children.
Evidence indicates that children’s cold medicines don’t really help and may cause an assortment of side effects, particularly to young children. According to leading pharmaceutical manufacturer MCR American Pharmaceuticals there are four different categories of drugs that are in question, they include: + Cough suppressants. + Cough expectorants. + Decongestants. + Antihistamines.
MCR American Pharmaceuticals explains the problem with kids’ cold medicines is that many of the medications were often not studied in children. Instead, they were studied in adults, and those results were then applied to children. However, it’s not clear that adults and children will react to these medicines in the same way.
The FDA recommends the following: + Never give cold and cough medicines to children under 4 unless recommended by a doctor. + Never give adult medicines to children. + Carefully follow the instructions listed on the medicines’ box. + Use the measuring spoon, dropper, or dosing cup. + Take your child to the doctor if symptoms worsen or don’t improve within a few days.
So what are parents supposed to do? MCR American Pharmaceuticals manufactures a medication group called Maxiphen that is ideal for children. The Maxiphen product family includes Maxiphen and Maxiphen DM. MCR American Pharmaceuticals explains that Maxiphen is an expectorant and decongestant that contains Phenylephrine and Guaifenesin. Maxiphen helps patients who have congestion due to the common cold, sinusitis, hay fever, and allergic rhinitis.
Maxiphen helps loosen mucus in the lungs, throat and bronchi. Furthermore, it helps relieve a stuffy nose caused by a cold, virus, the flu (influenza), sinusitis, or allergies. Maxiphen works to de-clog the nose and help customers breath better. MCR American Pharmaceuticals explains the benefit to such a medication is the low doses of Pseudoephedrine and Guaifenesin. The low dosage of such ingredients ensures the medication is suitable for young ages.
The Maxiphen product family also includes Maxiphen DM. MCR American Pharmaceuticals explains that Maxiphen DM is an expectorant, decongestant, and suppressant that contains Pseudoephedrine, Guaifenesin, and Dextromethorphan and is strong enough to cure post nasal drip cough. Maxiphen DM eliminates excess mucus, and loosens mucus in the lungs, throat and bronchi. Furthermore, it helps relieve a stopped-up nose caused by a cold, virus, the flu, sinusitis, or allergies.
For those younger than six, MCR American Pharmaceuticals manufactures Congestinex C. Congestinex C can help calm a runny nose and may stop sneezing. MCR American Pharmaceuticals designed Congestinex C to suit young children by using lower doses of Chlorpheniramine, and Dextromethorphan. In addition, Congestinex C arrives in a tasty grape flavor and in a liquid substance that tends to be more appealing to young children.
Parents should be hesitant with the cold and cough medicines they give their kids. According to the FDA, not all types of medicines are safe for young children. Fortunately there are several pharmaceutical manufacturers like MCR American Pharmaceuticals that manufacture medicines that are safe and effective for younger ages.
MCR American Pharmaceuticals is a specialty pharmaceutical company focused on the marketing and development along with sales and distribution of the highest quality pharmaceuticals. MCR American Pharmaceuticals’ products are marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and local pharmacies.
For additional information, interview and image request contact Virtuos Online.